Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News electroCore, Inc. ECOR

Healthcare Medical Devices
electroCore, Inc. is a commercial stage bioelectronic medicine and wellness company. It provides non-invasive vagus nerve stimulation (nVNS) technology platform. The Company’s product categories include Handheld, personal use medical devices for the management and treatment of certain medical conditions such as primary headache, and Handheld, personal use consumer products utilizing nVNS... see more

Recent & Breaking News (NDAQ:ECOR)

gammaCore (Non-Invasive Vagus Nerve Stimulation; nVNS) Reduces Symptoms of Acute Withdrawal in Patients with Opioid Use Disorder

GlobeNewswire September 7, 2022

electroCore to Participate at Upcoming Investor Conferences

GlobeNewswire September 6, 2022

electroCore to Participate at Canaccord Genuity 42nd Annual Growth Conference

GlobeNewswire August 5, 2022

electroCore Announces Record Second Quarter 2022 Financial Results

GlobeNewswire August 4, 2022

electroCore to Announce Second Quarter 2022 Financial Results on August 4

GlobeNewswire July 28, 2022

electroCore Provides Select Second Quarter 2022 Financial Guidance

GlobeNewswire July 12, 2022

electroCore, Inc. Announces Study of gammaCore Sapphire(TM) for the Treatment of Post-COVID Syndrome

GlobeNewswire July 7, 2022

electroCore Announces Listing Transfer to the Nasdaq Capital Market

GlobeNewswire June 23, 2022

electroCore, Inc. Announces gammaCore(TM) Non-Invasive Vagus Nerve Stimulator Available Through National Spine and Pain Centers

GlobeNewswire May 24, 2022

electroCore to Participate at Upcoming Investor Conferences

GlobeNewswire May 18, 2022

electroCore Announces Record First Quarter 2022 Financial Results

GlobeNewswire May 5, 2022

electroCore to Announce First Quarter 2022 Financial Results on May 5

GlobeNewswire April 28, 2022

electroCore Completes Sale of New Jersey Tax Benefits

GlobeNewswire April 26, 2022

electroCore Announces Publication of Investigator-Initiated Trial Data for SAVIOR-1 in COVID-19 Patients in Frontiers in Neurology

GlobeNewswire April 21, 2022

gammaCore(TM) Non-Invasive Vagus Nerve Stimulation (nVNS) Selected for Department of Defense Biotech Optimized for Operational Solutions and Tactics (BOOST) Program

GlobeNewswire April 19, 2022

electroCore Provides Business Update and Select First Quarter 2022 Financial Guidance

GlobeNewswire April 12, 2022

electroCore Announces Exclusive License Agreement with Teijin for Japan Territory

GlobeNewswire April 5, 2022

electroCore Announces Dr. Peter Staats to Keynote the Fifth Annual Bioelectronic Medicine Forum in New York

GlobeNewswire March 23, 2022

electroCore to Present at 2022 Maxim Virtual Growth Conference

GlobeNewswire March 22, 2022

electroCore Announces Fourth Quarter and Full Year 2021 Financial Results

GlobeNewswire March 10, 2022